1Anonymous (2002) Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 106, 3143–3421.
2Balkau, B, Vernay, M, Mhamdi, L, Novak, M, Arondel, D, Vol, S, Tichet, J & Eschwege, E (2003) The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study. Diabetes Metab 29, 526–532.
3Ford, ES, Giles, WH & Mokdad, AH (2004) Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 27, 2444–2449.
4Reaven, GM (1991) Resistance to insulin-stimulated glucose uptake and hyperinsulinemia: role in non-insulin-dependent diabetes, high blood pressure, dyslipidemia and coronary heart disease. Diabetes Metab 17, 78–86.
5Dandona, P, Aljada, A, Chaudhuri, A, Mohanty, P & Garg, R (2005) Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111, 1448–1454.
6Reaven, GM (2005) The metabolic syndrome: requiescat in pace. Clin Chem 51, 931–938.
7Meigs, JB, D'Agostino, RB Sr, Wilson, PW, Cupples, LA, Nathan, DM & Singer, DE (1997) Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes 46, 1594–1600.
8Meigs, JB (2000) Invited Commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am J Epidemiol 152, 908–911; .
9Hanley, AJ, Festa, A, D'Agostino, RB Jr, Wagenknecht, LE, Savage, PJ, Tracy, RP, Saad, MF & Haffner, SM (2004) Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity. Diabetes 53, 1773–1781.
10Kahn, R, Buse, J, Ferrannini, E & Stern, M (2005) The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28, 2289–2304.
11Barnard, RJ, Roberts, CK, Varon, SM & Berger, JJ (1998) Diet-induced insulin resistance precedes other aspects of the metabolic syndrome. J Appl Physiol 84, 1311–1315.
12Colagiuri, S & Brand Miller, JC (1997) The metabolic syndrome: from inherited survival trait to a health care problem. Exp Clin Endocrinol Diabetes 105, Suppl. 2, 54–60.
13Daly, M (2003) Sugars, insulin sensitivity, and the postprandial state. Am J Clin Nutr 78, 865S–872S.
14Reaven, GM (2005) The insulin resistance syndrome: definition and dietary approaches to treatment. Annu Rev Nutr 25, 391–406.
15Carpentier, YA, Portois, L & Malaisse, WJ (2006) n-3 fatty acids and the metabolic syndrome. Am J Clin Nutr 83, 1499S–1504S.
16Feldeisen, SE & Tucker, KL (2007) Nutritional strategies in the prevention and treatment of metabolic syndrome. Appl Physiol Nutr Metab 32, 46–60.
17Blouet, C, Mariotti, F, Azzout-Marniche, D, Mathé, V, Mikogami, T, Tome, D & Huneau, JF (2007) Dietary cysteine alleviates sucrose-induced oxidative stress and insulin resistance. Free Radic Biol Med 42, 1089–1097.
18Lavigne, C, Marette, A & Jacques, H (2000) Cod and soy proteins compared with casein improve glucose tolerance and insulin sensitivity in rats. Am J Physiol Endocrinol Metab 278, E491–E500.
19Lavigne, C, Tremblay, F, Asselin, G, Jacques, H & Marette, A (2001) Prevention of skeletal muscle insulin resistance by dietary cod protein in high fat-fed rats. Am J Physiol Endocrinol Metab 281, E62–E71.
20Blouet, C, Mariotti, F, Mikogami, T, Tome, D & Huneau, JF (2006) Meal cysteine improves postprandial glucose control in rats fed a high-sucrose meal. J Nutr Biochem 18, 519–524.
21Bos, C, Airinei, G, Mariotti, F, Benamouzig, R, Berot, S, Evrard, J, Fenart, E, Tome, D & Gaudichon, C (2007) The poor digestibility of rapeseed protein is balanced by its very high metabolic utilization in humans. J Nutr 137, 594–600.
22Scherrer, U & Sartori, C (2000) Defective nitric oxide synthesis: a link between metabolic insulin resistance, sympathetic overactivity and cardiovascular morbidity. Eur J Endocrinol 142, 315–323.
23Chan, NN & Chan, JC (2002) Asymmetric dimethylarginine (ADMA): a potential link between endothelial dysfunction and cardiovascular diseases in insulin resistance syndrome? Diabetologia 45, 1609–1616.
24Mariotti, F, Hammiche, A, Blouet, C, Dare, S, Tome, D & Huneau, JF (2006) Medium-term methionine supplementation increases plasma homocysteine but not ADMA and improves blood pressure control in rats fed a diet rich in protein and adequate in folate and choline. Eur J Nutr 45, 383–390.
25Anderson, ME (1985) Determination of glutathione and glutathione disulfide in biological samples. Methods Enzymol 113, 548–555.
26Schafer, FQ & Buettner, GR (2001) Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 30, 1191–1212.
27Wallace, TM, Levy, JC & Matthews, DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27, 1487–1495.
28Monzillo, LU & Hamdy, O (2003) Evaluation of insulin sensitivity in clinical practice and in research settings. Nutr Rev 61, 397–412.
29Belfiore, F & Iannello, S (1998) Insulin resistance in obesity: metabolic mechanisms and measurement methods. Mol Genet Metab 65, 121–128.
30Oliart Ros, RM, Torres-Marquez, ME, Badillo, A & Angulo Guerrero, O (2001) Dietary fatty acids effects on sucrose-induced cardiovascular syndrome in rats. J Nutr Biochem 12, 207–212.
31Aguilera, AA, Diaz, GH, Barcelata, ML, Guerrero, OA & Ros, RM (2004) Effects of fish oil on hypertension, plasma lipids, and tumor necrosis factor-alpha in rats with sucrose-induced metabolic syndrome. J Nutr Biochem 15, 350–357.
32Blouet, C, Mariotti, F, Azzout-Marniche, D, Bos, C, Mathe, V, Tome, D & Huneau, JF (2006) The reduced energy intake of rats fed a high-protein low-carbohydrate diet explains the lower fat deposition, but macronutrient substitution accounts for the improved glycemic control. J Nutr 136, 1849–1854.
33Roberts, CK, Barnard, RJ, Sindhu, RK, Jurczak, M, Ehdaie, A & Vaziri, ND (2005) A high-fat, refined-carbohydrate diet induces endothelial dysfunction and oxidant/antioxidant imbalance and depresses NOS protein expression. J Appl Physiol 98, 203–210.
34Reaven, GM (2005) Why Syndrome X? From Harold Himsworth to the insulin resistance syndrome. Cell Metab 1, 9–14.
35Haffner, SM, Valdez, RA, Hazuda, HP, Mitchell, BD, Morales, PA & Stern, MP (1992) Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 41, 715–722.
36Petersen, KF, Dufour, S, Savage, DB, et al. (2007) The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proc Natl Acad Sci U S A 104, 12587–12594.
37Ghafoorunissa, , Ibrahim, A, Rajkumar, L & Acharya, V (2005) Dietary (n-3) long chain polyunsaturated fatty acids prevent sucrose-induced insulin resistance in rats. J Nutr 135, 2634–2638.
38Milagro, FI, Campion, J & Martinez, JA (2006) Weight gain induced by high-fat feeding involves increased liver oxidative stress. Obesity (Silver Spring) 14, 1118–1123.
39Sumiyoshi, M, Sakanaka, M & Kimura, Y (2006) Chronic intake of high-fat and high-sucrose diets differentially affects glucose intolerance in mice. J Nutr 136, 582–587.
40Barnard, RJ, Faria, DJ, Menges, JE & Martin, DA (1993) Effects of a high-fat, sucrose diet on serum insulin and related atherosclerotic risk factors in rats. Atherosclerosis 100, 229–236.
41Berger, JJ & Barnard, RJ (1999) Effect of diet on fat cell size and hormone-sensitive lipase activity. J Appl Physiol 87, 227–232.
42Lee, JS, Pinnamaneni, SK, Eo, SJ, Cho, IH, Pyo, JH, Kim, CK, Sinclair, AJ, Febbraio, MA & Watt, MJ (2006) Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites. J Appl Physiol 100, 1467–1474.
43Riccardi, G, Aggett, P, Brighenti, F, et al. (2004) PASSCLAIM – body weight regulation, insulin sensitivity and diabetes risk. Eur J Nutr 43, Suppl. 2, II7–II46.
44Guarino, MP, Afonso, RA, Raimundo, N, Raposo, JF & Macedo, MP (2003) Hepatic glutathione and nitric oxide are critical for hepatic insulin-sensitizing substance action. Am J Physiol Gastrointest Liver Physiol 284, G588–G594.
45Guarino, MP & Macedo, MP (2006) Co-administration of glutathione and nitric oxide enhances insulin sensitivity in Wistar rats. Br J Pharmacol 147, 959–965.
46Lands, LC, Grey, VL & Smountas, AA (1999) Effect of supplementation with a cysteine donor on muscular performance. J Appl Physiol 87, 1381–1385.
47Mariotti, F, Simbelie, KL, Makarios-Lahham, L, Huneau, JF, Laplaize, B, Tome, D & Even, PC (2004) Acute ingestion of dietary proteins improves post-exercise liver glutathione in rats in a dose-dependent relationship with their cysteine content. J Nutr 134, 128–131.
48Jobgen, WS, Fried, SK, Fu, WJ, Meininger, CJ & Wu, G (2006) Regulatory role for the arginine-nitric oxide pathway in metabolism of energy substrates. J Nutr Biochem 17, 571–578.
49Frayn, KN (2001) Adipose tissue and the insulin resistance syndrome. Proc Nutr Soc 60, 375–380.
50Van Pelt, RE, Evans, EM, Schechtman, KB, Ehsani, AA & Kohrt, WM (2002) Contributions of total and regional fat mass to risk for cardiovascular disease in older women. Am J Physiol Endocrinol Metab 282, E1023–E1028.
51Buemann, B, Sorensen, TI, Pedersen, O, et al. (2005) Lower-body fat mass as an independent marker of insulin sensitivity—the role of adiponectin. Int J Obes (Lond) 29, 624–631.
52Sakai, Y, Ito, H, Egami, Y, Ohoto, N, Hijii, C, Yanagawa, M, Satoh, S & Jingu, S (2005) Favourable association of leg fat with cardiovascular risk factors. J Intern Med 257, 194–200.
53Roberts, CK, Vaziri, ND, Liang, KH & Barnard, RJ (2001) Reversibility of chronic experimental syndrome X by diet modification. Hypertension 37, 1323–1328.